Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction.

Zahra Lotfollahi,Ana P Q Mello,Francisco A H Fonseca, Luciene O Machado, Andressa F Mathias,Maria C Izar,Nagila R T Damasceno,Cristiano L P Oliveira,Antônio M F Neto

PloS one（2022）

引用 3|浏览2

暂无评分

摘要

The quality of LDL particles was influenced by the antiplatelet/lipid-lowering strategy, with ticagrelor being associated with the best performance with both lipid-lowering therapies. Trial registration: NCT02428374.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要